Guardant Health (GH) is up 6.9% today. Here is some analysis on what might have caused this price movement. ([investors.guardanthealth.com](https://investors.guardanthealth.com/press-releases/press-releases/2026/Guardant-Health-Reports-Second-Quarter-2026-Financial-Results-and-Increases-2026-Revenue-Guidance/default.aspx))
Analysis: The move appears tied mainly to Guardant Health’s second-quarter 2026 results, which showed fast revenue growth and another increase to full-year guidance. Investors also seemed encouraged by strong Shield screening momentum and several recent commercial and regulatory wins that support the company’s growth story, even though net loss remained elevated. ([investors.guardanthealth.com](https://investors.guardanthealth.com/press-releases/press-releases/2026/Guardant-Health-Reports-Second-Quarter-2026-Financial-Results-and-Increases-2026-Revenue-Guidance/default.aspx))
Details:
Sources:
Guardant Health Investor Relations, SEC, American Cancer Society ([investors.guardanthealth.com](https://investors.guardanthealth.com/press-releases/press-releases/2026/Guardant-Health-Reports-Second-Quarter-2026-Financial-Results-and-Increases-2026-Revenue-Guidance/default.aspx))
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$GH Insider Trading Activity
$GH insiders have traded $GH stock on the open market 60 times in the past 6 months. Of those trades, 1 have been purchases and 59 have been sales.
Here’s a breakdown of recent trading of $GH stock by insiders over the last 6 months:
- AMIRALI TALASAZ (Co-Chief Executive Officer) has made 0 purchases and 19 sales selling 520,000 shares for an estimated $67,405,344.
- HELMY ELTOUKHY (Co-Chief Executive Officer) has made 0 purchases and 7 sales selling 100,000 shares for an estimated $12,629,968.
- KUMUD KALIA (Chief Information Officer) has made 1 purchase buying 600 shares for an estimated $78,456 and 6 sales selling 49,618 shares for an estimated $5,067,010.
- JOHN G. SAIA (Chief Legal Officer) has made 0 purchases and 5 sales selling 30,000 shares for an estimated $3,381,064.
- CHRIS FREEMAN (Chief Commercial Officer) sold 24,406 shares for an estimated $2,896,360
- MEGHAN V. JOYCE has made 0 purchases and 4 sales selling 10,000 shares for an estimated $1,269,808.
- STEVE E. KROGNES sold 9,294 shares for an estimated $1,231,521
- IAN T CLARK sold 6,876 shares for an estimated $735,048
- MICHAEL BRIAN BELL (Chief Financial Officer) has made 0 purchases and 2 sales selling 5,000 shares for an estimated $518,351.
- MEDINA MANUEL HIDALGO has made 0 purchases and 5 sales selling 3,550 shares for an estimated $382,920.
- TERILYN J. MONROE (Chief People Officer) sold 3,832 shares for an estimated $355,149
- MUSA TARIQ has made 0 purchases and 6 sales selling 2,763 shares for an estimated $341,563.
- MYRTLE S POTTER sold 1,556 shares for an estimated $204,084
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$GH Hedge Fund Activity
We have seen 252 institutional investors add shares of $GH stock to their portfolio, and 217 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TWO SIGMA INVESTMENTS, LP added 2,057,628 shares (+94.7%) to their portfolio in Q1 2026, for an estimated $190,063,098
- PIER 88 INVESTMENT PARTNERS LLC added 2,050,380 shares (+30064.2%) to their portfolio in Q1 2026, for an estimated $189,393,600
- GOLDMAN SACHS GROUP INC added 1,808,266 shares (+68.8%) to their portfolio in Q1 2026, for an estimated $167,029,530
- FMR LLC added 1,719,648 shares (+71.8%) to their portfolio in Q1 2026, for an estimated $158,843,885
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,387,611 shares (+24.6%) to their portfolio in Q1 2026, for an estimated $128,173,628
- JENNISON ASSOCIATES LLC removed 966,559 shares (-82.6%) from their portfolio in Q1 2026, for an estimated $89,281,054
- WESTFIELD CAPITAL MANAGEMENT CO LP added 823,349 shares (+152.7%) to their portfolio in Q1 2026, for an estimated $76,052,747
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$GH Analyst Ratings
Wall Street analysts have issued reports on $GH in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 02/20/2026
To track analyst ratings and price targets for $GH, check out Quiver Quantitative's $GH forecast page.
$GH Price Targets
Multiple analysts have issued price targets for $GH recently. We have seen 21 analysts offer price targets for $GH in the last 6 months, with a median target of $160.0.
Here are some recent targets:
- Shannon O'Callaghan from Morgan Stanley set a target price of $175.0 on 07/09/2026
- Patrick Donnelly from Citigroup set a target price of $215.0 on 07/08/2026
- Michael Ryskin from B of A Securities set a target price of $190.0 on 07/06/2026
- Vijay Kumar from Evercore ISI Group set a target price of $200.0 on 07/06/2026
- Eve Burstein from Bernstein set a target price of $200.0 on 07/02/2026
- Mark Massaro from BTIG set a target price of $190.0 on 07/01/2026
- Subbu Nambi from Guggenheim set a target price of $160.0 on 06/29/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
